The due diligence process is the most important part of any merger or acquisition, and without the proper tools to conduct a comprehensive review of key areas, laboratory leaders risk making a bad call.
Not going through this process with accurate data can lead to:
Give your team the tools necessary to confidently provide you with a clear understanding of the M&A, so that you can make a sound investment. Provide them with a clear picture of:
Gather, Analyze, and Make a Profit
Without a modern tool to provide you clear and meaningful outputs, you will continue to rely on manual excel-based reports that do not call out all the key factors affecting your purchase or partnership.
By taking the time to thoroughly review all aspects of the other party’s RCM, you can:
Gistia Intelligence provides clear and meaningful outputs of the organization’s RCM data.
Gistia Intelligence helps your organization in several key areas:
Review both top-line revenue numbers and more detailed information such as accounts receivable (A/R) days, denials rate, and collection rates. Gistia brings this information front and center in a comprehensive and easily digestible format.
This encompasses everything from the number of full-time equivalent (FTE) employees dedicated to RCM to the organization’s billing and coding processes. Gistia layers this information in an accurate way to gain insight into its value.
Review the RCM software currently in place, as well as any other technology that impacts the revenue cycle. As seasoned technology experts in lab RCM, Gistia can help identify and alert you to such future concerns.
Schedule a call to get started
We help you stay financially compliant at every stage